Chapter 1 Flashcards
The coding sequence, which dictates protein sequences, is contained within
Exons
Mutations in genes encoding components of the telomere complex are associated with the bone marrow failure syndrome
Dyskeratosis congenita
The spliceosome is a large complex of proteins and five
Small nuclear ribonuclear proteins (snRNPs)
What are the 3 splicing factor mutations found in approximately 50% of patients with MDS?
SF3B1, U2AF1, SRSF2
DNA sequences that lie in proximity to and regulate the expression of genes, which encode protein, are termed
Cis-acting regulatory elements
A special type of enhancer is locus control region (LCR), which is located approximately 50 kilobases upstream from this gene.
Beta-globin
In addition to being complexed with protein, the DNA of inactive genes is modified by the addition of methyl groups to
Cytosine residues
The addition of methyl groups to cytosine residues of inactive genes results in
5-methylcytosine (5mC)
Is methylation generally a marker of an active or inactive gene?
Inactive
DNA methylation is performed by enzymes called
DNA methyltransferases
When genes are ______, they are usually heavily methylated in contrast to the nonimprinted copy of the allele.
Imprinted
When genes are imprinted, they are usually heavily ______ in contrast to the nonimprinted copy of the allele.
Methylated
Hematopoietic stem cells display an age-related decline in function and a relative loss of lymphoid differentiation potential, and these changes are associated with site-specific changes in
DNA methylation
Hematopoietic stem cells display an age-related decline in function and a relative loss of ______ differentiation potential, and these changes are associated with site-specific changes in DNA methylation.
Lymphoid differentiation
Mutations in enzymes affecting DNA methylation, most notably the DNA methyltransferase ______ are common in AML.
DNMT3A
Mutations in DNMT3A are found in approximately ______ of AML patients.
20%
What are the 3 major enzymes affecting DNA methylation that are recurrently mutated in AML?
DNMT3A, TET2, IDH1/2
Small molecule inhibitors of DNA methyltransferases are used in the treatment of disorders that are characterized by aberrant DNA methylation such as
MDS, AML